Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

被引:0
|
作者
Chang, Heng-Jui [1 ]
Ke, Chiao-Hsu [2 ]
Wang, Yu-Shan [3 ,4 ]
机构
[1] Wesing Surg Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
[2] Natl Taipei Univ Technol, Inst Chem Engn, Dept Chem Engn & Biotechnol, Taipei, Taiwan
[3] Natl Taiwan Univ, Sch Vet Med, Dept Vet Med, Taipei, Taiwan
[4] Uni Pharm Co Ltd, Taipei, Taiwan
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
immune checkpoint inhibitor; hyperthermia; modulated electro-hyperthermia; cholangiocarcinoma; immunotherapy;
D O I
10.3389/fonc.2024.1421340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cholangiocarcinoma is a malignancy known for its aggressiveness and limited treatment options. The malignant tumor behaviors include intrahepatic recurrence, regional lymph node (LN) metastasis, peritoneal carcinomatosis, and lung metastasis. Herein, we reported a case of lymphatic recurrence in an intrahepatic cholangiocarcinoma patient after surgery, adjuvant concurrent chemoradiotherapy (CCRT), who experienced a remarkable response to a combination therapy. However, the patient failed to undergo radiotherapy or other invasive local therapy and therefore received Opdivo (nivolumab) in combination with chemotherapy (FOLFOX) and modulated electro-hyperthermia. Notably, after these medical interventions, this patient had a complete response (CR) to treatments, in which no lymph node metastasis occurred, and a significantly decreased tumor marker, CA 19-9, level was found. This case highlights the potential of multiple anti-tumor therapies, including immune checkpoint inhibitors, chemotherapy, and hyperthermia, in managing challenging cholangiocarcinoma cases.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
    Fletcher, James
    Bird, Robert
    Mclean, Andrew J. W.
    O'Byrne, Kenneth
    Xu, Wen
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (11):
  • [32] Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series
    Jessica Atieh
    Jordan Sack
    Richard Thomas
    Osama E. Rahma
    Michael Camilleri
    Shilpa Grover
    Digestive Diseases and Sciences, 2021, 66 : 1974 - 1980
  • [33] A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
    Guan, Shasha
    Zhang, Linlin
    Zhang, Junyan
    Song, Wenjing
    Zhong, Diansheng
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [34] Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy
    Glick, Matthew
    Baxter, Chase
    Lopez, David
    Mufti, Kashif
    Sawada, Stephen
    Lahm, Tim
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [35] Fulminant immune-related colitis after dual checkpoint inhibitor therapy: case report
    Lukin, Robert
    Ciner, Aaron
    IMMUNOTHERAPY, 2024, 16 (14-15) : 943 - 948
  • [36] Metastatic stomach lymphoepithelioma-like carcinoma and immune checkpoint inhibitor therapy: A case report
    Chen, Guo-Feng
    Wang, Jun
    Yan, Yu
    Xu, Song
    Chen, Jian
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (05):
  • [37] Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma A case report
    Langan, Ewan A.
    Budner, Kaja
    Zillikens, Detlef
    Terheyden, Patrick
    MEDICINE, 2021, 100 (16) : E25513
  • [38] Cytokine release syndrome induced by immune checkpoint inhibitor treatment for uterine cervical cancer recurrence: A case report
    Sekimata, Mao
    Kinjo, Yasuyuki
    Tohyama, Atsushi
    Murakami, Midori
    Hashiwaki, Sayumi
    Saito, Yuma
    Higami, Shota
    Hagimoto, Marina
    Taketomi, Ruka
    Hoshino, Kaori
    Harada, Hiroshi
    Ueda, Taeko
    Kurita, Tomoko
    Matsuura, Yusuke
    Yoshino, Kiyoshi
    ONCOLOGY LETTERS, 2024, 28 (01)
  • [39] A case of coagulation factor V inhibitor induced by immune checkpoint inhibitor therapy
    Haruta, Yuki
    Azuma, Masanori
    Sado, Toshikatsu
    Saito, Ryuichi
    Miyazaki, Yoshimune
    Noda, Akihiro
    Kitagawa, Reina
    Hori, Yasutaka
    Fujimoto, Sayaka
    Hasegawa, Yoshinori
    Ueda, Tetsuya
    Yamamura, Ryosuke
    RESPIROLOGY CASE REPORTS, 2024, 12 (02):
  • [40] Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy
    Sato, Yasunori
    Tanaka, Shogo
    Kinoshita, Masahiko
    Takemura, Shigekazu
    Shinkawa, Hiroji
    Kokudo, Takashi
    Hasegawa, Kiyoshi
    Tanaka, Hiromu
    Yoshimoto, Hidero
    Mori, Akira
    Yamamura, Minako
    Sasaki, Motoko
    Harada, Kenichi
    Kubo, Shoji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2020, 27 (11) : 860 - 869